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egulation of membrane-type 1 matrix metalloprotein-
ase  (MT1-MMP) by different extracellular matrices
(ECMs) on human endothelial cells (ECs) has been
investigated. First, MT1-MMP is found at the intercellular
contacts of conﬂuent ECs grown on 
 
 
 
1 integrin–dependent
matrix such as type 1 collagen (COL I), ﬁbronectin (FN), or
ﬁbrinogen (FG), but not on gelatin (GEL) or vitronectin
(VN). The novel localization of MT1-MMP at cell–cell
contacts is assessed by confocal videomicroscopy of MT1-
MMP-GFP–transfected ECs. Moreover, MT1-MMP colocalizes
with 
 
 
 
1 integrins at the intercellular contacts, whereas it is
 
preferentially found with 
 
 
 
v
 
 
 
3 integrin at motility-associated
structures on migrating ECs. In addition, clustered integrins
recruit MT1-MMP and neutralizing anti-
 
 
 
1 or anti-
 
 
 
v integrin
R
 
mAb displace MT1-MMP from its speciﬁc sites, pointing to
a biochemical association that is ﬁnally demonstrated by
coimmunoprecipitation assays. On the other hand, COL I,
FN, or FG up-regulate cell surface MT1-MMP on conﬂuent
ECs by an impairment of its internalization, whereas expres-
sion and internalization are not modiﬁed on GEL or VN. In
addition, MT1-MMP activity is diminished in conﬂuent ECs
on COL I, FN, or FG. Finally, MT1-MMP participates and
cooperates with 
 
 
 
1 and 
 
 
 
v
 
 
 
3 integrins in the migration of
ECs on different ECM. These data show a novel mechanism
 
by which ECM regulates MT1-MMP association with 
 
 
 
1 or
 
 
 
v
 
 
 
3 integrins at distinct cellular compartments, thus modu-
lating its internalization, activity, and function on human ECs.
 
Introduction
 
During angiogenesis, ECM changes dynamically to provide
new binding sites to endothelial cell (EC)* receptors involved in
adhesion and migration (Stupack and Cheresh, 2002). ECM
supports endothelial cell attachment by binding to distinct
adhesion receptors being the integrins 
 
 
 
2
 
 
 
1, 
 
 
 
5
 
 
 
1, and
 
 
 
v
 
 
 
3, the principal endothelial receptors for type I collagen
(COL I), fibronectin (FN), and vitronectin (VN), respectively
(Bazzoni et al., 1999). Integrin expression is modulated during
angiogenesis by different factors and plays important roles
during endothelial migration and the formation of new vessels
 
as shown by the blocking effects of 
 
 
 
v
 
 
 
3 antagonists (Stupack
and Cheresh, 2002).
The dynamics of ECM during the angiogenic response is
accomplished by the deposition of provisional components as
well as by its remodeling by proteases (Werb, 1997). The major
enzymes involved in degrading ECM belong to the matrix
metalloproteinase (MMP) family (Nagase and Woessner,
1999). Membrane-type 1 matrix metalloproteinase (MT1-
MMP),  one of the membrane-anchored metalloproteinases,
degrades several ECM components including type I, II,
and III collagens, gelatin (GEL), VN, FN, fibrinogen (FG),
and laminins 1 and 5 apart from activating pro-MMP-2 and
pro-MMP-13 (Werb, 1997). MT1-MMP is also the best
candidate for focused proteolysis because it is recruited to
the invadopodia and to the leading edge of human melanoma
cells (Nakahara et al., 1997; Lehti et al., 2000). Proteolytic
ECM remodeling not only removes ECM, but also provides
a promigratory environment. Thus, cleavage of laminin-5 by
MT1-MMP induces epithelial cell migration (Koshikawa et
al., 2000). In turn, integrins, by interaction with ECM, regulate
pro-MMP-2 activation and MT1-MMP expression in human
capillary ECs and in tumor cells (Stanton et al., 1998; Yan et
al., 2000; Ellerbroek et al., 2001). Recent studies have demon-
strated a functional interaction between MT1-MMP and
integrins. Thus, it is known that 
 
 
 
v
 
 
 
3, induced on vascular
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sprouts during angiogenesis, interacts with MMP-2, a substrate
for MT1-MMP (Brooks et al., 1996). It has also been re-
ported the cooperative role of MT1-MMP and 
 
 
 
v
 
 
 
3 in acti-
vating pro-MMP-2 (Hofmann et al., 2000; Deryugina et al.,
2001). Finally, MT1-MMP has been shown to directly par-
ticipate in 
 
 
 
v processing during its maturation, thus modu-
lating the adhesive and migratory behavior of tumor cells
(Deryugina et al., 2002; Ratnikov et al., 2002). However,
the mechanisms by which ECM and integrins might regu-
late MMP functionality in human ECs remain unexplored.
Here, we report that ECM modulates MT1-MMP associ-
ation with 
 
 
 
1 and 
 
 
 
v
 
 
 
3 integrins at specific cell sites on
ECs, thus regulating MT1-MMP internalization, expres-
sion, and activation. Moreover, MT1-MMP and integrins
are shown to cooperate during the migration of human ECs,
a critical step in the angiogenic response.
 
Results
 
MT1-MMP localizes at the intercellular contacts of ECs 
on COL I, FN, or FG
 
The effect of different ECM in regulating MT1-MMP on
human ECs was investigated. First, the localization of MT1-
MMP was found to be different depending on the matrix. As
shown in Fig. 1 A, MT1-MMP decorated intercellular con-
tacts of ECs adhered to COL I, FN, or FG, in contrast to
the diffuse staining observed on GEL and VN. To elucidate
the adhesion receptors contributing to attachment of ECs
to the different ECM, adhesion assays in the presence of neu-
tralizing anti-integrin antibodies were performed. As shown in
Fig. 1 B, ECs mainly adhered to COL I or FN in a 
 
 
 
1 inte-
grin–dependent manner, whereas contribution of 
 
 
 
v
 
 
 
3 inte-
grins was lower (90 and 60% inhibition, respectively). In
contrast, EC adhesion to GEL or VN was greatly reduced by
anti-
 
 
 
v or anti-
 
 
 
v
 
 
 
3, and at a lower extent by anti-
 
 
 
1 inte-
grin mAb (80 and 50% inhibition, respectively). Both 
 
 
 
1 and
 
 
 
v integrins similarly contributed to EC adhesion to FG (Fig.
1 B). Thus, distinct recognition of ECM by integrins seems to
regulate MT1-MMP subcellular localization on human ECs.
The novel MT1-MMP localization at cell–cell contacts
was also assessed through an independent approach. Full-
length MT1-MMP was fused with GFP, and the construct
was transfected into ECs. MT1-MMP-GFP protein had an
expected molecular mass of 
 
 
 
90 kD and was active as ana-
lyzed by Western blot and zymography (Fig. 2, A and B,
respectively). The dynamics of MT1-MMP subcellular lo-
calization was observed by time-lapse confocal videomicros-
copy. Transiently transfected ECs displayed an enrichment
of MT1-MMP-GFP at cell sites contacting other cells (Fig.
2 C; Video 1). In addition, an active traffic of MT1-MMP-
GFP–positive intracellular vesicles to the membrane, form-
ing clusters at motility-associated structures, was also ob-
served (Fig. 2 C; Video 1).
 
MT1-MMP distinctly colocalizes with 
 
 
 
1 or 
 
 
 
v
 
 
 
3 
integrins on ECs depending on the ECM and the 
migratory state
 
Because MT1-MMP could be found at interendothelial con-
tacts and motility-associated structures of ECs, its putative
association with integrins also present at those sites was in-
vestigated. Interestingly, MT1-MMP colocalized with 
 
 
 
1 in-
tegrins at the intercellular junctions of confluent ECs on
COL I, but not at the motility structures of migrating cells
(Fig. 3 A). 
 
 
 
1 integrins were occasionally observed at the
leading edge and lamellipodia of ECs together with MT1-
MMP (unpublished data). Upon wound-induced migration,
MT1-MMP was recruited to discrete regions of motile struc-
tures independently of the matrix (GEL or COL I), where it
colocalized with 
 
 
 
v
 
 
 
3 integrin (Fig. 3 B). However, 
 
 
 
v
 
 
 
3
integrin had a diffuse pattern on confluent ECs and was not
observed at cell–cell contacts on COL I (Fig. 3 B).
To assess the putative role of the MT1-MMP cytoplasmic
domain in its matrix-regulated localization, ECs were tran-
siently transfected with either MT1-MMP-GFP or MT1-
MMP
 
 
 
cyt-GFP constructs. As shown for the full-length
protein, the MT1-MMP
 
 
 
cyt-GFP fusion protein had an ex-
pected molecular mass of 
 
 
 
90 kD and proteolytic activity in
both FG and GEL zymography; however, the expression of
mature MT1-MMP
 
 
 
cyt-GFP was lower than the full-length
protein as demonstrated by the Western blot analysis (Fig. 2
A). Although MT1-MMP-GFP was found colocalizing with
 
 
 
1 or 
 
 
 
v
 
 
 
3 integrins at some intercellular contacts as well as
at motility structures of migrating ECs on COL I, respec-
tively (Fig. 3 C), MT1-MMP
 
 
 
cyt-GFP could rarely be ob-
served at those cell sites colocalizing with integrins (Fig. 3 C).
The GFP protein transfected into ECs did not display any
specific localization (Fig. 3 C). These data suggest that the cy-
Figure 1. MT1-MMP localizes at the cell–cell contacts of ECs 
grown on COL I, FN, or FG. (A) ECs were grown to confluency on 
coverslips coated with 1% GEL or 10  g/ml VN, COL I, FN, or FG 
for 24 h and then stained for immunofluorescence analysis with the 
anti-MT1-MMP mAb LEM-2/15. Negative control of ECs on COL I 
without primary antibody is also included. Bar, 20  m. (B) Adhesion 
assays of ECs to plates coated with 1% GEL or 10  g/ml VN, COL I, 
FN, or FG were performed for 30 min at 37 C in the absence or 
presence of 10  g/ml neutralizing anti-integrin mAb ( 1,  v, or 
 v 3). The arithmetic mean   SD of three independent experiments 
run in triplicate is shown.  
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tosolic domain of MT1-MMP might participate in its local-
ization with either 
 
 
 
1 or 
 
 
 
v
 
 
 
3 integrins at specific cell sites.
 
MT1-MMP can associate with 
 
 
 
1 and 
 
 
 
v
 
 
 
3 integrins 
on human ECs
 
Because MT1-MMP was observed to colocalize with 
 
 
 
1 and
 
 
 
v
 
 
 
3 integrins at cell–cell contacts and motility structures,
respectively, the association of these proteins was further in-
vestigated. As shown in Fig. 4 A, 
 
 
 
1 integrin clustering in-
duced by COL I–coated beads resulted in an efficient redis-
tribution of MT1-MMP around the clustered integrins.
Similarly, 
 
 
 
v
 
 
 
3 integrin clustering also promoted rearrange-
ment of MT1-MMP around the COL I–coated beads (Fig.
4 A). However, no MT1-MMP staining was observed
around occasional CD31 clustering, and also, CD31 did not
redistribute around 
 
 
 
1 or 
 
 
 
v
 
 
 
3 integrins (Fig. 4 A). Similar
results were obtained with GEL, FN, or FG-coated latex
beads, although the efficiency in recruiting 
 
 
 
1 and 
 
 
 
v
 
 
 
3 in-
tegrins as well as in the recruitment of MT1-MMP by these
integrins was slightly different depending on the ECM used
as shown in Fig. 4 A.
Furthermore, treatment of ECs grown on COL I with the
neutralizing anti-
 
 
 
1 integrin mAb LIA1/2 impaired MT1-
MMP localization at the cell–cell contacts, although it pre-
served 
 
 
 
1 integrin staining at these sites as well as MT1-
MMP localization at motility structures (Fig. 4 B). On the
contrary, treatment of ECs with the neutralizing anti-
 
 
 
v in-
tegrin mAb ABA 6D1 blocked MT1-MMP staining at mo-
tility-associated clusters, but neither affect 
 
 
 
v integrin local-
ization at these sites nor MT1-MMP localization at cell–cell
contacts (Fig. 4 B).
Finally, the biochemical association of MT1-MMP with
 
 
 
1 or 
 
 
 
v
 
 
 
3 integrins was directly assessed by coimmunopre-
cipitation assays. Immunoprecipitation of 
 
 
 
1 integrins from
ECs lysed in mild conditions showed a faint but consistent
band of 60 kD, corresponding to mature MT1-MMP (Fig.
4 C). However, 
 
 
 
v integrins coprecipitated the immature
and mature forms of MT1-MMP as a double band of 63
and 60 kD, with 63 kD being the main one (Fig. 4 C). Anti-
MT1-MMP immunoprecipitates also contained traces of 
 
 
 
1
and 
 
 
 
v integrins under these conditions (Fig. 4 C).
 
MT1-MMP surface expression is distinctly modulated 
by integrin–ECM interactions on human ECs
The intensity of MT1-MMP staining seemed to be higher
when localized at the cell–cell contacts of ECs on COL I,
FN, or FG compared with GEL or VN (Fig. 1 A). To inves-
tigate this point further, the expression of MT1-MMP on
different matrices was quantitated. The expression of MT1-
MMP on confluent ECs increased after 6 or 24 h of attach-
ment to COL I, FN, or FG in contrast to GEL or VN as as-
sessed by flow cytometry; this ECM-mediated MT1-MMP
up-regulation diminished in the presence of cycloheximide
(Fig. 5, A and B). Because migration induced an increase of
MT1-MMP expression on ECs on GEL (Gálvez et al.,
2001), the effect of migration on different matrix in mod-
ulating MT1-MMP expression was also analyzed. Wound-
induced migration further enhanced MT1-MMP surface
expression on VN, COL I, FN, and FG, suggesting a ma-
trix-independent effect; moreover, the migration-induced
increase was inhibited in the presence of cycloheximide (Fig.
5, A and B).
Figure 2. MT1-MMP-GFP is 
dynamically mobilized to cell–cell 
contacts in live ECs. (A and B) Lysates 
from transiently transfected ECs with 
GFP, MT1-MMP-GFP, or MT1-MMP  
cyt-GFP constructs were analyzed by 
Western blot (A) or FG and GEL 
zymography (B). EC lysates are also 
included as controls. MT1-MMP cyt-GFP 
sample was loaded two- to threefold the 
full length in Western and zymography 
assays. The ratio of MMP-2 activation 
(MMP-2/pro-MMP-2) was 0.2, 0.8, and 
0.7 (n   2) for GFP, MT1-MMP-GFP, 
and MT1-MMP cyt-GFP transfected 
cells, respectively. (C) MT1-MMP 
dynamic localization was analyzed by 
live time-lapse fluorescence confocal 
videomicroscopy. A video sequence 
tracking the spatial and temporal 
distribution of MT1-MMP-GFP on ECs 
migrating on COL I was performed. In 
each panel, a projection of several 
representative horizontal sections of a 
confocal stack extracted from the video 
sequence at the specified time (0, 1, 2, 3, 
and 4 h) is shown. DIC and fluorescence 
images are merged and presented in the 
bottom panels. Arrowheads, arrows, 
and asterisks indicate the clustering of 
MT1-MMP-GFP at cell–cell contacts, motility structures, and intracellular vesicles, respectively. A representative out of eight independent 
experiments is shown. Bar, 20  m. Video available at http://www.jcb.org/cgi/content/full/jcb.200205026/DC1.512 The Journal of Cell Biology | Volume 159, Number 3, 2002
Figure 3. MT1-MMP colocalizes with 
 1 and  v 3 integrins at cell–cell 
contacts or motility structures, 
respectively. (A and B) MT1-MMP 
subcellular distribution was analyzed 
by immunofluorescence staining of 
confluent or wound-stimulated ECs 
grown on GEL or COL I. (A) MT1-MMP 
(green) redistributes to cell–cell contacts 
on ECs grown on COL I where it 
colocalizes with  1 integrins (red) as 
shown in the merged image (yellow). 
(B) Upon wound-induced migration, 
MT1-MMP (green) mobilizes to motility 
structures (arrowheads) colocalizing 
with  v 3 integrin (red) on GEL or COL I 
as shown in the merged image (yellow). 
(C) ECs were transiently transfected with 
GFP, MT1-MMP-GFP, or MT1-MMP  
cyt-GFP constructs and then plated 
at subconfluency on COL I. GFP 
fluorescence of transfected ECs (green), 
staining with either anti- 1 or anti- v 3 
mAb (red), and the merged images 
(yellow) are shown. Insets enlarging 
(2.25 ) an area of the merged images 
(arrowheads) are included. The pattern 
of staining of GFP-transfected ECs and 
the corresponding DIC image are shown 
as control. Bars (A–C), 20  m. MT1-MMP and integrins in human endothelial cells | Gálvez et al. 513
Next, we analyzed whether ECM was mediating the ef-
fects observed in MT1-MMP expression by distinct clus-
tering of integrins. First, clustering of  1 integrins was
independently achieved by coating plates with either the ac-
tivating TS2/16 or the neutralizing LIA1/2 anti- 1 integrin
mAb. Both mAb promoted a consistent accumulation of cell
surface MT1-MMP on ECs, pointing to clustering rather
than activation as the mechanism responsible for integrin-
mediated effects (Fig. 5 C). Additionally, clustering  v 3
integrins by coating plates with LM609 mAb increased
MT1-MMP expression at a lower extent (Fig. 5 C). Anti- 3
and anti- 5 integrin mAb also up-regulated MT1-MMP
surface expression in contrast to anti- 2 integrin and to the
control anti-CD31 mAb (Fig. 5 C).
MT1-MMP level was also analyzed by Western blot of to-
tal cellular lysates from ECs grown on different ECM. No
major changes in the whole amount of MT1-MMP were de-
tected on lysates of ECs grown on GEL and VN versus COL
I, FN, or FG in contrast to wound-healing stimulation that
induced a similar MT1-MMP up-regulation on all sub-
strates (Fig. 5 D). These results suggest that other mecha-
nisms apart from increased expression are likely involved in
the up-regulation of MT1-MMP on the surface of confluent
ECs by distinct ECM.
Integrin–ECM interactions regulate MT1-MMP 
internalization on human ECs
MT1-MMP internalization has been proposed as a new
mechanism for regulating MT1-MMP balance on the cell
surface (Jiang et al., 2001; Uekita et al., 2001). Because the
ECM-mediated increase in MT1-MMP endothelial surface
expression did not correlate with changes in the total MT1-
Figure 4. MT1-MMP can associate 
with both  1 and  v 3 integrins. 
(A) Double staining of COL I-coated 
beads added to migratory ECs with 
biotinylated anti-MT1-MMP and anti- 1 
or anti- v 3 integrin mAb was performed. 
MT1-MMP (green) is recruited around 
beads where  1 or  v 3 integrin (red) 
are clustered. CD31 staining (red) was 
also included as negative control. DIC 
images are also shown. Bar, 20  m. The 
percentage of stained beads with the 
different combination of mAb and the 
efficiency of beads in clustering  1 or 
 v 3 integrins are shown in the right 
panel. The arithmetic mean of three 
independent experiments is represented. 
(B) MT1-MMP (green) and integrin (red) 
staining was performed on confluent or 
migratory ECs grown on COL I and 
preincubated or not with the neutralizing 
anti- 1 LIA1/2 or anti- v integrin ABA 
6D1 mAb. Note in merged images 
(yellow) that MT1-MMP colocalization 
at cell–cell contacts and motile structures 
(arrowheads) is impaired by pretreatment 
with anti- 1 or anti- v integrin mAb, 
respectively. Bar, 20  m. (C) Immuno-
precipitation with anti- 1 TS2/16 or 
anti- v 3 integrin LM609 mAb from ECs 
on COL I lysed in mild conditions was 
performed. Western blot of these immuno-
precipates with anti-MT1-MMP LEM-2/15 
mAb shows bands of 60 kD (asterisk) 
and 63/60 kD (arrowhead/asterisk), 
respectively, that correspond to the 
mature (60 kD) and immature (63 kD) 
forms of MT1-MMP, as well as other 
nonspecific lower bands. Anti-MT1-MMP 
LEM-2/63 mAb also pulls down faint 
bands corresponding to  1 and  v 
integrins. One out of three independent 
experiments is shown. 514 The Journal of Cell Biology | Volume 159, Number 3, 2002
MMP amount analyzed by Western blot, the putative regu-
latory role of ECM on MT1-MMP internalization was in-
vestigated. Transferrin receptor was included in the analysis
as a well-characterized marker of endothelial endocytosis
(Moos and Morgan, 2000).
The internalization kinetics of MT1-MMP on GEL was
rapid, being complete at 6 h; however, no MT1-MMP in-
ternalization was observed on ECs grown on COL I, and
after 6 h all the MT1-MMP still remained at the cell sur-
face (Fig. 6, A and C). VN behaved similarly to GEL and
FN or FG to COL I in this respect (unpublished data).
The effect of COL I on impairing MT1-MMP internaliza-
tion was mimicked by clustering  1 integrins; in contrast,
clustering  v 3 integrins resulted in a similar MT1-MMP
internalization to that obtained on GEL (Fig. 6 B). Be-
sides, MT1-MMP internalization on COL I was com-
pletely restored upon wound-induced migration of ECs
(Fig. 6, A and C). The association of MT1-MMP with  1
or  v 3 integrins might be related to the regulation of its
internalization because  1 integrins were not internalized
compared with  v 3 integrin that was completely inter-
nalized after 6 h independently of matrix or migration (un-
published data).
The initially labeled MT1-MMP at the cell surface was al-
most completely recovered in permeabilized cells after 6 h of
receptor internalization, ruling out shedding as an important
mechanism for the decrease of the protease at the cell surface
(Fig. 6, A and B). To confirm this point, MT1-MMP inter-
nalization was also visualized by immunofluorescence mi-
croscopy. As shown in Fig. 6 D, after 6 h at 37 C, MT1-
MMP was internalized in a vesicle-like pattern similar to the
transferrin receptor on ECs grown on GEL in contrast to
COL I on which MT1-MMP staining remained mostly at
the cell–cell contacts.
MT1-MMP activity is diminished on human ECs on  1 
integrin–dependent substrates
Because ECM modulates MT1-MMP localization and in-
ternalization, the effect of distinct ECM on MT1-MMP ac-
tivity was also assessed by FG and GEL zymography. De-
spite higher levels of MT1-MMP on the cell membrane, no
detectable FG degradation was observed on confluent ECs
grown on COL I, FN, or FG compared with GEL or VN, in
which a basal fibrinolytic activity was present (Fig. 7 A).
Moreover, wound-induced migration stimulated FG degra-
dation in ECs cultured on COL I, FN, or FG, but much less
Figure 5. MT1-MMP expression upon integrin-
mediated ECM interactions on ECs. (A) Surface 
expression of MT1-MMP was analyzed by flow 
cytometry with the anti-MT1-MMP mAb 
LEM-2/15 on confluent or wound-stimulated 
ECs grown for 6 or 24 h on 1% GEL or 10  g/ml 
VN, COL I, FN, or FG. The negative control 
X63 is also represented. A representative out of 
five experiments is shown. (B) Mean fluorescence 
intensity values (logarithmic scale) of MT1-MMP 
staining of ECs grown on different ECM for 24 h 
either at confluency or migratory conditions are 
shown. Intensity upon pretreatment with 
cycloheximide is also presented (ND, not 
determined). The arithmetic mean of three 
independent experiments is represented. The 
increments of MT1-MMP expression on COL I, 
FN, and FG were statistically significant 
(P   0.02). (C) MT1-MMP surface expression 
was analyzed by flow cytometry on ECs grown 
on plates coated with 10  g/ml of anti- 1activ 
TS2/16, anti- 1neutr LIA1/2, anti- v 3 LM609, 
anti- 2 12F1, anti- 3 VJ1/6, anti- 5 P1D6, or 
anti-CD31 TP1/15 mAb for 24 h. MFI values 
(logarithmic scale) are included. Biotinylated 
anti-MT1-MMP LEM-2/15 and Streptavidin–Alexa 
488 were used. X63 was included as negative 
control. A representative out of four experiments 
is shown. (D) MT1-MMP expression was 
analyzed by Western blot of lysates from control 
or wound-healing–stimulated ECs grown for 
24 h on 1% GEL or 10  g/ml VN, COL I, FN, or 
FG. Anti-MT1-MMP mAb LEM-2/15 was used. 
Anti-VE cadherin was included as loading 
control. A representative out of six experiments 
is shown. MT1-MMP and integrins in human endothelial cells | Gálvez et al. 515
efficiently than on GEL (Fig. 7 A). Similar results were ob-
tained when assessing pro-MMP-2 processing by GEL zy-
mography of lysates and supernatants (Fig. 7 A). Moreover,
the fraction of pro-MMP-2 associated to the cell lysate was
reduced in resting ECs grown on COL I, FN, or FG in con-
trast to the increase of this pro-form observed in the corre-
sponding supernatant (Fig. 7 A). No significant changes in
TIMP-2 levels were detected under the different conditions
(unpublished data). These data show a down-regulation of
MT1-MMP activity on  1 integrin–dependent substrates.
ECM effects on MT1-MMP activity were likely mediated
by integrin interactions. Thus, clustering  1 integrins with
the two different mAbs, activating TS2/16 and neutralizing
LIA1/2, mimicked the effects seen on COL I, FN, or FG
with no MT1-MMP activation on confluent cells and re-
duced MT1-MMP activation on migratory cells (Fig. 7 B).
Figure 6. MT1-MMP internalization is impaired on confluent ECs grown on COL I. (A) MT1-MMP internalization was analyzed by flow 
cytometry (linear scale) on ECs grown on GEL or COL I-coated plates in the absence or presence of wound stimulation. MT1-MMP surface 
staining on nonpermeabilized as well as total MT1-MMP staining on permeabilized ECs at 0 h and after 6 h of mAb binding at 37 C is 
presented. X63 was used as negative control. A representative out of three experiments is shown. (B) MT1-MMP internalization was assessed 
on confluent ECs grown on anti- 1 TS2/16 or anti- v 3 LM609 mAb-coated plates. Data on GEL are included for comparison. MT1-MMP 
surface staining on nonpermeabilized as well as total MT1-MMP staining on permeabilized EC at 0 h and after 6 h of mAb binding at 37 C is 
presented. X63 was used as negative control. A representative out of three experiments is shown. (C) Percentage of internalization of MT1-MMP, 
CD31, and TfnR was calculated as described in Materials and methods. CD31 and TfnR were included as negative and positive control of 
receptor internalization. The arithmetic mean   SD of three independent experiments is represented. (D) Confluent ECs on GEL or COL I 
were labeled without fixing with anti-MT1-MMP LEM-2/15 mAb for 20 min at RT. ECs were either fixed (0 h) or transferred to 37 C for 6 h to 
allow labeled-receptor internalization, and then fixed and stained with a secondary antibody. TfnR labeling is also included as positive 
control of internalization. Bar, 20  m.516 The Journal of Cell Biology | Volume 159, Number 3, 2002
In contrast, clustering  v integrins with ABA 6D1 mAb elic-
ited an activation of MT1-MMP comparable to that ob-
served on GEL or VN (Fig. 7 B). Therefore, MT1-MMP
activity is down-regulated by  1 integrin–mediated interac-
tions with COL I, FN, and FG, whereas  v integrin-medi-
ated interactions with GEL or VN, like wound-induced mi-
gration, enable MT1-MMP activation.
To analyze the relation between regulation of MT1-MMP
internalization and activity, okadaic acid (a modulator of re-
ceptor internalization) was used (Parton et al., 1994). Interest-
ingly, upon treatment with okadaic acid, MT1-MMP internal-
ization increased up to 50% in confluent ECs grown on COL
I. As shown in Fig. 7 C, treatment with okadaic acid also re-
stored the activity of MT1-MMP on COL I, pointing to a link
between MT1-MMP internalization and its activation state.
MT1-MMP participates and cooperates with integrins 
during EC migration on ECM
During EC migration, MT1-MMP localizes at migratory
structures on different ECMs, its expression increases, and
its activity is up-regulated. Therefore, the role of MT1-
MMP during EC migration on ECM was investigated. First,
it was observed that anti-MT1-MMP inhibitory mAb LEM-
2/15, when used at saturating doses of 10  g/ml, prevented
EC migration on COL I, FN, FG, or VN by more than 50%
on wound-healing and transmigration assays (Fig. 8 A). In-
terestingly, the Fab monovalent fragment of anti-MT1-
MMP LEM-2/15 mAb inhibited EC migration on COL I at
a similar extent to the complete IgG, suggesting that cluster-
ing of MT1-MMP is not necessary for the impairment of
migration. Anti-VE cadherin and anti- 1 integrin TS2/16
mAb or anti- v integrin ABA 6D1 mAb were also included
as negative and positive controls of inhibition, respectively
(Fig. 8 A). The role of MT1-MMP in EC migration was also
explored by transiently transfecting ECs with GFP, MT1-
MMP-GFP, or MT1-MMP cyt-GFP constructs and assess-
ing their ability to migrate across COL I-coated filters. Inter-
estingly, ECs transfected with the truncated mutant showed
an impaired migration when compared with ECs transfected
with the full-length protein, suggesting that intact MT1-
MMP is required for migration of ECs on COL I (Fig. 8 B).
Moreover, MT1-MMP–dependent migration was signifi-
cantly inhibited by anti-MT1-MMP mAb on ECs trans-
fected with MT1-MMP-GFP (Fig. 8 B).
Finally, we wanted to analyze whether the association of
MT1-MMP with  1 and  v integrins might also have a
functional relevance during EC migration. The combination
of the inhibitory anti-MT1-MMP mAb LEM-2/15 at sub-
optimal doses with anti- 1 and anti- v integrin mAb re-
sulted in an additive inhibitory effect on EC migration on
COL I in wound-healing assays (Fig. 8 C). Furthermore,
pretreatment of ECs with suboptimal doses of anti-MT1-
MMP and either anti- 1 or anti- v integrin mAb had an
additive inhibitory effect on EC transmigration on COL I or
VN, i.e., the migration was completely abolished when the
three mAbs were used in combination (Fig. 8 C). Similar re-
sults were obtained when cells were migrating on FN or FG
(unpublished data). These findings suggest a functional co-
operation of MT1-MMP with  1 and  v integrins in mod-
ulating the migratory potential of human ECs.
Discussion
We have reported a novel role of the ECM in regulating
MT1-MMP subcellular localization, internalization, and ac-
tivity in human ECs through its differential association with
 1 or  v 3 integrins at cell–cell contacts and motility struc-
tures, respectively (Fig. 9).
MT1-MMP has been involved in pericellular proteolysis
by focusing ECM degradation to specific cell sites such as
invadopodia or the cellular leading edge (Nakahara et al.,
1997; Lehti et al., 2000). However, we have demonstrated a
novel localization of MT1-MMP at endothelial cell–cell
contacts on COL I, FN, and FG, where it colocalizes with
 1 integrins. Dynamic assessment of MT1-MMP localiza-
tion by fluorescence microscopy in live cells during EC mi-
Figure 7. COL I, FN, and FG decrease MT1-MMP–mediated 
degradation of FG and processing of pro-MMP-2. (A) Lysates and 
supernatants from resting or wound-healing–induced ECs on distinct 
ECM were analyzed by FG and GEL zymography. A representative 
out of four experiments is shown. (B) Lysates from resting or wound-
healing–stimulated ECs grown on plates coated with 10  g/ml of 
anti- 1activ TS2/16, anti- 1neutr LIA1/2, anti- v integrin ABA 6D1, or 
anti-CD31 TP1/15 mAb included as control were analyzed by FG 
and GEL zymography. Lysates of ECs grown on GEL or COL I are 
also included for comparison. A representative out of three 
experiments is shown. (C) Lysates from confluent ECs grown on 
COL I and pretreated or not overnight with 10  M okadaic acid 
were analyzed by FG and GEL zymography. A representative out of 
two experiments is shown. MT1-MMP and integrins in human endothelial cells | Gálvez et al. 517
gration confirmed an enrichment of MT1-MMP at areas
where ECs contact each other. The direct association of
MT1-MMP with  1 integrins and/or with other receptors
present at endothelial junctions (such as claudins) might be
involved in the recruitment to these sites as recently shown
in 293T-transfected cells (Miyamori et al., 2001). Con-
ceivably, MT1-MMP at EC contacts might constitute a
reservoir ready to be mobilized to other cell sites or to be
activated in situ. Moreover, emerging new functions for
MT1-MMP, such as cleavage of endothelial intercellular re-
ceptors for detachment of ECs from each other during mi-
gration or for leukocyte transmigration might rely on that
new localization. However, under migratory conditions and
independently of the ECM, MT1-MMP is recruited to re-
gions on ECs likely involved in ECM degradation colocaliz-
ing with  v 3 similarly to tumoral cells (Hofmann et al.,
2000; Deryugina et al., 2001). Thus, integrins could form
complexes with proteases to focus EC proteolytic activity
more efficiently. In this regard, it has been proposed that
 v 3/MT1-MMP cooperation would be required to fully
Figure 8. Role of MT1-MMP itself or in cooperation with  1 or  v integrins on EC migration on ECM. (A) Migration of ECs on 10  g/ml 
COL I, FN, FG, or VN was assessed by wound-healing and/or transmigration assays at 8 and 5 h, respectively. Migration was analyzed in the 
absence or presence of saturating doses (10  g/ml) of the inhibitory anti-MT1-MMP mAb LEM-2/15. The inhibitory effects obtained were 
statistically significant for wound healing (*, P   0.04; **, P   0.01) and for transmigration assays ( , P   0.02;   , P   0.015). Fab 
monovalent fragments of anti-MT1-MMP LEM-2/15 mAb used at 10  g/ml also had an inhibitory effect on COL I (  , P   0.015). Anti- 1 
TS2/16 and anti- v integrin ABA 6D1 mAb were also included. Anti-VE-cadherin TEA1/31 mAb was used as negative control. The arithmetic 
mean   SD of a representative out of four independent experiments run in duplicate is shown. (B) ECs were transiently transfected with GFP, 
MT1-MMP-GFP, or MT1-MMP cyt-GFP constructs and then assayed for migration across COL I-coated filters for 5 h. The number of 
transfected cells counted in eight independent fields and normalized respect the efficiency of transfection is represented. The impaired 
migration observed with the mutant as well as the inhibition of migration of MT1-MMP-GFP transfected cells by anti-MT1-MMP mAb were 
statistically significant (*, P   0.03). The arithmetic mean   SD of two independent experiments run in duplicate is shown. (C) EC migration 
on COL I or transmigration across COL I or VN-coated filters were analyzed at 8 and 5 h, respectively, in the absence or presence of suboptimal 
doses (5  g/ml) of one, two, or three of anti-MT1-MMP LEM-2/15, anti- 1 TS2/16, or anti- v integrin ABA 6D1 mAb. Anti-CD31 mAb TP1/15 
was included as negative control. The inhibitory effects obtained were statistically significant for wound-healing (*, P   0.04; **, P   0.02) 
and transmigration assays ( , P   0.01;   , P   0.005). The arithmetic mean   SD of a representative out of three independent experiments 
run in duplicate is shown.518 The Journal of Cell Biology | Volume 159, Number 3, 2002
activate pro-MMP-2 in human breast carcinoma cells (Der-
yugina et al., 2001). Also, a protease-docking function of
 3 1 integrin at invadopodia by forming a functional com-
plex with seprase has been shown in melanoma cells (Muel-
ler et al., 1999). Interestingly, MT1-MMP cytosolic domain
might be participating in the localization with  1 and  v 3
integrins at cell–cell contacts and motility structures, respec-
tively, as suggested by immunofluorescence staining of trans-
fected ECs.
The colocalization of MT1-MMP with  1 or  v 3 inte-
grins pointed to a biochemical association of these receptors
on ECs. MT1-MMP association with  v 3 or  1 integrins
had been suggested by chemical cross-linking on breast
carcinoma cells and by studies with anti- 1 integrin mAb-
coated beads in ovarian carcinoma cells, respectively (Deryu-
gina et al., 2001; Ellerbroek et al., 2001). We have demon-
strated by coimmunoprecipitation assays that MT1-MMP
can associate with  1 and  v 3 integrins on primary ECs.
This interaction might be important for MT1-MMP local-
ization because anti- 1 or anti- v 3 integrin neutralizing
mAb impaired MT1-MMP localization at cell–cell contacts
and motile structures, respectively. Interestingly,  1 inte-
grins are mainly associated to the 60-kD mature form of
MT1-MMP, pointing to an association with MT1-MMP at
the cell membrane. On the other hand,  v integrins associ-
ate to both the 63-kD immature and the 60-kD mature
forms of MT1-MMP, suggesting that both proteins might
travel together from intracellular synthesis toward the cell
membrane in similar compartments, such as caveolae (Puy-
raimond et al., 2001). In this regard, the processing of the
immature pro- v chain by MT1-MMP has recently been
demonstrated (Ratnikov et al., 2002).
Regulation of cellular proteolysis by ECM-induced in-
crease of protease expression was first reported in fibroblasts
interacting with FN (Werb et al., 1989). We have demon-
strated two different mechanisms for regulating MT1-MMP
expression by ECM interactions on ECs. First, MT1-MMP
can be up-regulated by an increase in its synthesis de novo,
as seems to be the case upon migration-inducing conditions
independent of the ECM type. Accordingly, it has previ-
ously been reported that an ECM-mediated signaling in-
creased Egr-1–dependent transcriptional expression of MT1-
MMP in rat ECs (Haas et al., 1999). Interestingly, our data
reveal an alternative mechanism by which ECM modulates
MT1-MMP expression by regulating its internalization. In-
ternalization of MT1-MMP through a dileucine cytoplasmic
motif has recently been reported on MT1-MMP–transfected
cells, but its endogenous regulation has not been character-
ized (Jiang et al., 2001; Uekita et al., 2001). We demonstrate
that MT1-MMP internalization is abrogated on confluent
ECs grown on  1 integrin–dependent ECM (COL I, FN,
or FG) compared with the constitutive endocytosis on  v 3
integrin–dependent substrates (GEL or VN). This mecha-
nism might explain the ECM-mediated MT1-MMP in-
crease in the absence of mRNA changes reported by other
groups (Stanton et al., 1998; Zhuge and Xu, 2001). The in-
crease in MT1-MMP surface expression is also achieved by
 1 integrin clustering with mAb anti- 1, anti- 3, or anti-
 5 integrins, but not by anti- 2 integrin mAb, pointing to
specific  1 integrins as responsible for the effect. Possibly,
clustering  1 integrins might induce phosphorylation or re-
cruit cytoskeletal/signaling machinery that could interfere
with the endocytosis motif, thus blocking MT1-MMP inter-
nalization. Additionally, physical retention of MT1-MMP
through distinct interactions with  v 3 or  1 integrins at
the cell membrane might enable or block MT1-MMP en-
docytosis. Interestingly, upon migration-inducing conditions,
MT1-MMP internalization is restored in accordance with
the requirement of MT1-MMP internalization for its func-
tion in cell migration and invasion recently reported (Jiang
et al., 2001; Uekita et al., 2001).
Surprisingly, MT1-MMP proteolytic activity is reduced
on COL I, FN, or FG despite its increased surface expres-
sion. Previous reports had shown an increase of MT1-
MMP/MMP-2 activation by distinct ECM such as FN or
COL I in tumoral or transformed cells (Stanton et al., 1998;
Ellerbroek et al., 2001). However, on human capillary cells
or fibroblasts, ECM induced a down-regulation of MMP-2
activation in accordance with our data (Werb et al., 1989;
Yan et al., 2000). This suggests that primary and tumor cells
might have different mechanisms for regulating MT1-MMP
activity through ECM interactions. The decrease in MT1-
MMP activity observed in confluent ECs on COL I corre-
lated with the blockade of its internalization. Interestingly,
treatment with okadaic acid that enforces MT1-MMP inter-
nalization on COL I restores MT1-MMP activity, pointing
to a causal relation between the blockade of MT1-MMP
internalization and the decrease of its activity.  1 integrin
association with MT1-MMP might directly interfere with
its catalytic domain or induce modifications around its in-
ternalization motif also affecting the oligomerization site
(Cys
574) required for its function (Lehti et al., 2002). Alter-
natively,  1 or  v 3 integrin–mediated signals might dis-
tinctly modulate MT1-MMP activity in accordance with
previous differences in signaling triggered by COL I and VN
reported during EC migration (Leavesley et al., 1993).
Independent of ECM, migration induces MT1-MMP lo-
calization at EC motility structures, an increase of its expres-
Figure 9. MT1-MMP is regulated by ECM and migration on human 
ECs. MT1-MMP in confluent ECs on COL I displays a localization at 
cell–cell contacts with  1 integrins, an impaired internalization 
rate, and a low enzymatic activity. MT1-MMP under migratory 
conditions exhibits a localization at motility structures with  v 3 
integrin, a high rate of internalization, and an induction of enzymatic 
activity. Blockade of MT1-MMP activity leads to an inhibition of EC 
migration that is larger when combined with neutralizing  1 and/or 
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sion without affecting internalization, and an up-regulation
of its activity pointing to an active role of this protease dur-
ing EC migration. Here, it is demonstrated that MT1-MMP
is required for EC migration on several ECM because both
the whole IgG as well as the Fab monovalent fragment of in-
hibitory anti-MT1-MMP mAb decreased EC migration; in
addition, the cytoplasmic deletion mutant of MT1-MMP
had impaired migratory ability on COL I, showing that in-
tact MT1-MMP is required for EC migration in accordance
with previous reports in other cell types (Lehti et al., 2000;
Uekita et al., 2001). Moreover, MT1-MMP cooperates with
 1 and  v 3 integrins in this respect because inhibition of
the three pathways in combination abrogates EC migration
on ECM. This effect may be due to overlapping or inde-
pendent mechanisms acting in concert. Thus, integrin-medi-
ated effects on migration are likely dependent on the regula-
tion of cell attachment/detachment as well as on signaling
through small GTPases (Schwartz and Shattil, 2000; Stu-
pack and Cheresh, 2002). However, the mechanisms by
which proteases play a role in cellular migration remain
largely undefined (Murphy and Gavrilovic, 1999). Interest-
ingly, no effect of the inhibitory anti-MT1-MMP mAb on
EC adhesion to ECM was observed, pointing to other mech-
anisms involved (unpublished data). MT1-MMP might reg-
ulate migration by unmasking cryptic migratory sites, as
shown for epithelial cells on laminin 5 (Koshikawa et al.,
2000), or as it might happen to  v 3 integrin that can bind
cleaved collagen (Messent et al., 1998); in this regard, pro-
teolysis of COL I was observed during EC migration (un-
published data). MT1-MMP-mediated processing of cell–
cell contact receptors might also favor detachment and
migration of ECs. In this regard, the ability of MT1-MMP
to process the transmembrane receptors CD44 and tissue
transglutaminase involved in tumor cell migration has been
shown (Belkin et al., 2001; Kajita et al., 2001). Direct mod-
ifications of integrin receptors by MT1-MMP might also be
relevant because MT1-MMP can process pro- v, - 5, and
- 3 integrins, and this processing seems to improve  v 3-
mediated signaling and migration (Deryugina et al., 2002;
Ratnikov et al., 2002). Therefore, there is a dual contribu-
tion of MT1-MMP and integrins in regulating EC migra-
tion on ECM, although more efforts are required to eluci-
date if there is a functional crosstalk between them.
In summary, the regulation of MT1-MMP depends on in-
tegrin interactions with the ECM found by ECs during their
migration. This might correlate with the sequential events of
detachment of basal membrane, remodeling of subendothe-
lial tissue and provisional matrix with appearance of new in-
tegrin ligands, and finally matrix deposition with arrest of
migration that takes place in vivo during angiogenesis, vascu-
lar injury, wound healing, or tissue remodeling.
Materials and methods
Antibodies and reagents
mAb anti- 1 integrins TS2/16 (Arroyo et al., 1992) and LIA1/2, anti- v
integrins ABA 6D1, anti-VE-cadherin TEA1/31, and anti-CD31 TP1/15
(Yáñez-Mó et al., 1998), anti- v 3 integrin LM609 (Brooks et al., 1996),
anti- 2 integrin 12F1 (Pischel et al., 1987), anti- 3 integrin VJ1/6 (Peñas et
al., 2000), anti- 5 integrin P1D6 (Wayner et al., 1989), anti-transferrin re-
ceptor FG2/12 (Sánchez-Madrid et al., 1985), and anti-MT1-MMP LEM-2/
15 and LEM-2/63 (Gálvez et al., 2001) have been described previously.
Anti-intermediate filament CHELO-3 mAb will be characterized else-
where. The monoclonal Ig (IgG1, ) from the P3X63 myeloma cell line was
used as negative control.
Type IV GEL, FN, and okadaic acid were purchased from Sigma-Aldrich.
COL I from ICN Biomedicals, and human plasma, plasminogen-depleted,
FG from Calbiochem-Novabiochem were also used. VN was a gift from
Dr. E. Dejana (FIRC Institute of Molecular Oncology, Milan, Italy; Dejana
et al., 1988).
Cells and cell cultures
Human ECs from umbilical vein were obtained and cultured as described
previously (Arroyo et al., 1992). Cells up to the third passage were used in
all the assays. ECs were changed to serum-free medium HE-SFM (Life
Technologies) and seeded on dishes coated with 1% GEL or VN, COL I,
FN, or FG at 10  g/ml before the functional assays were performed.
Immunofluorescence microscopy
ECs were grown on coverslips coated with different ECM until confluence.
Next, they were stimulated by disrupting the monolayer for 24 h, fixed,
and blocked as described previously (Gálvez et al., 2001). Coverslips were
incubated with the primary antibody (anti- v 3 LM609, anti- 1 TS2/16, or
anti-CD31 TP1/15 mAb) and labeled with a secondary Rhodamine X–con-
jugated goat anti–mouse antibody. After saturating coverslips with mouse
serum, cells were labeled with the anti-MT1-MMP LEM-2/15 biotinylated
mAb and then incubated with Streptavidin-Alexa 488. Samples were ex-
amined in a photomicroscope (DMR; Leica) with a 63  oil immersion ob-
jective, and images were recorded using a CCD camera from Leica.
ECs grown to confluence on COL I–coated coverslips were incubated
for 30 min at RT with 10  g/ml of the inhibitory anti- 1 (LIA1/2) or anti- v
integrin (ABA 6D1) mAb, and after 24 h at 37 C they were fixed and pro-
cessed for immunofluorescence assays as described above. Coverslips
were, in this case, incubated with the secondary Rhodamine X–conjugated
goat anti–mouse antibody, and after blocking with mouse serum, incu-
bated with the biotinylated anti-MT1-MMP LEM-2/15 mAb.
Adhesion assays
96-well plates (Costar) were coated with different ECM for 1 h at 37 C,
washed with PBS twice, saturated with PBS 1% BSA for 1 h at 37 C, and
again washed with PBS twice. ECs were resuspended in 1 ml HNSS (Bio-
Whittaker) with BCFECS at 1  M (Molecular Probes, Inc.) and incubated
at 37 C for 15 min. Next, they were washed twice with HNSS and resus-
pended in HE-SFM. Cells were preincubated with blocking antibodies for
20 min at RT, seeded at 3   10
4 cells per well, and then incubated at
37 C for 30 min on the plates. Finally, plates were washed with HNSS
twice and 100  l per well of lysis buffer (PBS   0.1% SDS) was added.
Absorbance was measured at 480 nm with a microplate fluorescence
reader (model FL500; Bio-Tek Instruments, Inc.). Experiments were per-
formed in triplicate.
Generation of MT1-MMP-GFP fusion protein and time-lapse 
confocal videomicroscopy analysis
MT1-MMP-GFP and MT1-MMP cyt-GFP were obtained using human
MT1-MMP cDNA cloned into pCDNA3.1 as template to amplify by PCR
the complete encoding region or the cytosolic domain truncated region
( Arg
563 Val
582), respectively, of this molecule without the stop codon. A
HindIII site was added to the 5  end and a SacII site at the 3  end. The PCR
products were cloned into pcDNA3.1/V5-HIS-TOPO from Invitrogen. PCR
products were then subcloned into pEGFP-N1. Sequence and orientation
was confirmed by sequence analysis. ECs were transiently transfected by
either calcium phosphate procedure or electroporation. In brief, 1.5   10
6
cells were transfected with 20  g DNA, and after 15 min, 2% FBS was
added; cells were plated in the presence of the DNA during 4 h. Alterna-
tively, 20  g DNA was transfected into 2   10
6 cells by electroporation at
200 V and 975  F using a Gene Pulser (Bio-Rad Laboratories). ECs trans-
fected with MT1-MMP-GFP constructs were used 24 h after transfection
for different assays (immunofluorescence microscopy and Transwell assays
as described). For videomicroscopy analysis, transfected ECs were grown
to confluence on COL I–coated glass bottom dishes (WillCo Wells B.V.)
and then placed on the microscope stage. Plates were maintained at 37 C
in a 5% CO2 atmosphere using an incubation system (PeCon). Confocal se-
ries of fluorescence and differential interference contrast (DIC) images
were simultaneously obtained at 3-min intervals during 2 h with a 40  oil
immersion objective. Images were processed and assembled into movies
using Leica confocal software.520 The Journal of Cell Biology | Volume 159, Number 3, 2002
Clustering integrin receptors with latex beads
2.97- m-diam latex beads (Sigma-Aldrich) were incubated at RT with
1% GEL or 10  g/ml COL I, FN, or FG in 1 ml buffer Tris-HCl 0.1 M, pH
9.0, overnight under agitation and then blocked with PBS plus 1% BSA
for 2 h at RT. Blocked beads were pelleted and resuspended in 1 ml
HNSS plus 0.1% azide. Matrix-adsorbed latex beads (2   10
4) were
added to EC plated on COL I–coated coverslips, incubated for 24 h,
washed, and fixed. Then, double-immunofluorescence staining was per-
formed. 100 latex beads per field with a total of 4 fields per coverslip
were counted.
Coimmunoprecipitation
Coimmunoprecipitation assays were essentially performed as described
previously (Yáñez-Mó et al., 1998). In brief, ECs were grown to conflu-
ence for 24 h on COL I–coated plates and lysed under mild conditions
(TBS, 1 mM CaCl2, 1 mM MgCl2, 1% Brij-96, 1% hemoglobin, and 1 mM
PMSF). Lysates were incubated for 2 h at 4 C with 40  l of the primary
mAb or glycine-Sepharose. Immunoprecipitates were washed twice with
1:10 dilution of the lysis buffer, boiled 5 min at 96 C in Laemmli buffer,
and separated by 12% SDS-PAGE under nonreducing conditions. After
transferring to a nitrocellulose membrane, Western blot was performed as
described above.
Flow cytometry analysis
ECs grown on plates coated with different ECM or 10  g/ml of different pu-
rified mAb were detached with PBS plus 5 mM EDTA on ice and washed
twice with PBS. In some cases, endothelial monolayer was disrupted to in-
duce migration as described previously (Gálvez et al., 2001). About 2  
10
5 cells were incubated with 100  l hybridoma culture supernatant or
biotinylated primary mAb for 20 min at 4 C. Cells were then washed with
PBS and incubated with 100  l of the proper dilution of a FITC-conjugated
anti–mouse Ig or Streptavidin-Alexa 488. Finally, fluorescence of samples
was acquired in logarithmic scale using a FACSCalibur™ flow cytometer
(Becton Dickinson).
Analysis of receptor internalization
ECs seeded on 6-well plates coated with different ECM were incubated
with the primary mAb at RT for 20 min, exhaustively washed with PBS,
and transferred to 37 C for 6 h to allow labeled-receptor internalization.
Half of the cells were then fixed and permeabilized for 10 min at 4 C with
lysis buffer (Becton Dickinson) and all processed for flow cytometry. The
fluorescence of permeabilized and nonpermeabilized samples was ac-
quired in linear scale for optimizing quantitation and analyzed at time
points 0 and 6 h. Anti-intermediate filament CHELO-3 mAb was used to
test efficiency of permeabilization that was always close to 100%. A simi-
lar approach was used to visualize receptor internalization under the fluo-
rescence microscope. Internalization percentages at 6 h were estimated
with Eq. 1:
(1)
Western blot assays
ECs were grown on different ECM and stimulated to migrate or not by dis-
rupting the monolayer. Resting and stimulated cells were washed twice
with PBS and directly lysed in Laemmli buffer on ice. Lysates were ana-
lyzed by Western blot as described previously (Gálvez et al., 2001).
Zymography assays
ECs were changed to serum-free medium 24 h before the assay. ECs were
grown on different ECM or on mAb-coated plates, and were then stimu-
lated to migrate or not by disrupting the monolayer. Culture supernatants
and cell lysates were processed by zymography as described previously
(Gálvez et al., 2001).
Wound-healing assays
ECs were grown to confluence on COL I, FN, or FG-coated 24-well plates.
Cells were preincubated with different purified mAb at 10  g/ml or at 5
 g/ml, when used in combination with other mAb, 30 min before the in-
jury. Next, wound-healing assays were performed as described previously
(Gálvez et al., 2001). Experiments were done in duplicate and four fields
of each well were recorded.
Internalization %
MFI in permeabilized cells () 6h MFI in nonpermeabilized cells () 6h –
MFI in nonpermeabilized cells () 0h
-------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
100 ×
=
Cell transmigration assay
EC transmigration assays were performed in 8- m pore Transwell cham-
bers (Costar). Cells were resuspended in serum-free medium and seeded at
2   10
4 cells/well on GEL, VN, COL I, FN, or FG-coated filters in the ab-
sence or presence of 5–10  g/ml different purified mAb on the upper
chamber. Transmigrated cells were stained and counted after 5 h of migra-
tion. Experiments were done in duplicate and four fields of each Transwell
were counted with a 40  objective in a microscope (Eclipse E400; Nikon).
In transmigration assays with transfected ECs, transmigrated cells in eight
independent fields were counted under the fluorescence microscope.
Statistical analysis
Tested and control samples in the functional assays were compared for sta-
tistical significance by t test.
Online supplemental material
In video 1 (corresponding to Fig. 2), an MT1-MMP-GFP–transfected EC
contacting with nontransfected ECs and migrating to the injury is recorded.
Online supplemental material available at http://www.jcb.org/cgi/content/
full/jcb.200205026/DC1.
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